BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/11/2022 8:36:00 AM | Browse: 192 | Download: 571
 |
Received |
|
2021-05-21 09:02 |
|
Peer-Review Started |
|
2021-05-21 09:07 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-28 04:30 |
|
Revised |
|
2021-06-28 07:18 |
|
Second Decision |
|
2022-06-01 02:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-06-03 21:27 |
|
Articles in Press |
|
2022-06-03 21:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-05-29 23:25 |
|
Typeset the Manuscript |
|
2022-07-02 10:51 |
|
Publish the Manuscript Online |
|
2022-07-11 08:36 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shou-Wu Lee, Yen-Chun Peng, Han-Chung Lien, Chung-Wang Ko, Chun-Fang Tung and Chi-Sen Chang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shou-Wu Lee, MD, PhD, Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650 Taiwan Boulevard, Sec. 4, Taichung 40705, Taiwan. ericest@vghtc.gov.tw |
| Key Words |
Hepatocellular carcinoma; Objective response; Overall survival; Transcatheter arterial chemoembolization; Barcelona Clinic Liver Cancer |
| Core Tip |
Transarterial chemoembolization (TACE) is the recommended treatment modality for the intermediate stage or the Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC) patients. However, due to the clinical heterogeneity in this population of patients, only some have a favorable outcome after TACE. In our study, we discovered that the intermediate stage HCC patients with smaller tumor size or within the up-to-7 criteria showed better survival outcomes for TACE. BCLC stage B subgroup is useful to predict refractoriness of HCC to TACE and to establish future therapeutic strategies. |
| Publish Date |
2022-07-11 08:36 |
| Citation |
Lee SW, Peng YC, Lien HC, Ko CW, Tung CF, Chang CS. Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization. World J Clin Cases 2022; 10(21): 7275-7284 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i21/7275.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i21.7275 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
